SUSTIVA

LOE Approaching

efavirenz

NDAORALTABLET
Approved
Feb 2002
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT06797674Phase 1Completed

A Study of the Effect Efavirenz on the Plasma Levels of MK-7602 in Healthy Participants (MK-7602-005)

Started Feb 2025
34 enrolled
Healthy
NCT06698016Phase 1Completed

A Study of the Effect of Efavirenz on the Plasma Levels of Nemtabrutinib (MK-1026-014)

Started Jul 2023
16 enrolled
Healthy
NCT05330273Phase 1Completed

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Efavirenz

Started Apr 2022
14 enrolled
Malaria
NCT05067439Phase 1Completed

A Study to Estimate the Effect of Multiple Dose Abrocitinib on Caffeine, Efavirenz, and Omeprazole in Healthy Participants

Started Oct 2021
26 enrolled
Healthy Participants
NCT04459598Phase 1Completed

A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants

Started Aug 2020
32 enrolled
Healthy SubjectsDrug-drug InteractionPharmacokinetics+1 more
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.